The FDA's Abbreviated New Drug Application (ANDA) process lets generic drugs reach the market faster and cheaper by proving equivalence to brand-name drugs. It saves billions annually and powers 90% of U.S. prescriptions.
Read More
Biomarkers are transforming cancer clinical trials by matching patients to treatments based on their unique biology. Learn how inclusion criteria now depend on genetic and molecular signals-and what you need to know to navigate eligibility.
Read More
After polyp removal, your next colonoscopy interval depends on polyp type, size, and number. Learn the updated 2020 guidelines for adenomas, serrated polyps, and high-risk cases to prevent colon cancer.
Read More
